A wealth of data indicates that certain genetic abnormalities can target specific cytotoxic drugs and intervene at an early step as a mechanism of resistance in the treatment of non-small-cell lung cancer. Therefore prescribing
M. Monzo, MD, PhD
Advertisement
Articles by M. Monzo, MD, PhD
Advertisement
Latest Updated Articles
- Novel Approaches in the Treatment of Non-Small-Cell Lung Cancer
Published: March 3rd 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
3
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
4
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
5
